On September 28, 2017, the Federal Trade Commission announced that it would be mailing out 5,379 refund checks to consumers who purchased Elimidrol marketed by Sunrise Nutraceuticals LLC as an effective opiate addiction withdrawal treatment. The refunds will total more than $210,000 and the average check will amount to $39. The FTC filed a complaint against the Boca Raton, Florida company in November of 2015.
It was alleged that Sunrise deceptively claimed that Elimidrol could alleviate the symptoms associated with opiate withdrawal. The company also claimed that the powdered drink mix, which consists of herbs and other compounds, would increase the user’s chance of overcoming their opiate addiction.
The court order settling the FTC’s charges bars Sunrise from making unsubstantiated health and efficacy claims. Sunrise has also agreed to pay $235,000 in refunds. Rust Consulting Inc. will serve as the refund administrator and has already started mailing refund checks to victims.
Consumers must cash the checks before November 27, 2017 or they’ll be voided.